Biosensis specializes in antibodies and reagents for Neuroscience, with particular emphasis on neurotrophins and neurotrophin receptors. In addition to neurotrophins, our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment, and neuro-metabolism. Areas of focus include Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation.
Biosensis’ product range includes not only a continuing growing line of neuroscience research antibodies but also an extensive and expanding line of 200+ quantitative research ELISAs, tissue staining and cell visualization reagents, and purified proteins targeted for neuroscience and cellular disease research. Our antibodies and reagents have been used in a wide range of techniques including western blot, immunohistochemistry, FACS analysis, real time imaging with confocal microscopy, biological inhibition and cell culture and cloning. Finally too, with a combined total of 340+ peer reviewed research publications and superb technical support and experience, Biosensis is able to offer a level of customer support and scientific expertise unmatched in the industry for Neuroscience and its related research fields.